DB
AMPH icon

Danske Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Danske Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,043
Closed -$614K – 1570
2025
Q3 		$614K Sell
23,043
-6,855
-23% -$177K ﹤0.01% 755
2025
Q2 		$686K Buy
+29,898
New +$742K ﹤0.01% 748
2024
Q4 		– Sell
-80,080
Closed -$3.89M – 1426
2024
Q3 		$3.89M Buy
+80,080
New +$3.51M 0.01% 584

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Danske Bank's AMPH Position: Q4 2025 in Review

Danske Bank sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2025, closing a stake of 23,043 shares — an estimated $614K sold.

Danske Bank first reported a position in AMPH in Q3 2024 and held it in 3 quarters. The position peaked at $3.89M in Q3 2024. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

  • Danske Bank reported no remaining Amphastar Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Danske Bank sold 23,043 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $614K.
  • Danske Bank first reported a position in Amphastar Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Danske Bank's Amphastar Pharmaceuticals position peaked at $3.89M in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on Danske Bank's 13F filing for Q4 2025, filed 2 Feb 2026.